Leisure 441 time physical activity and mortality: a detailed pooled analysis of the dose-response 442 relationship, JAMA Intern Med, vol.175, pp.959-967, 2015. ,
Physical activity and 444 risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke 445 events: systematic review and dose-response meta-analysis for the Global Burden of Disease 446 Study, BMJ, vol.354, p.3857, 2013. ,
Breast cancer treatment-associated cardiovascular toxicity and effects of 448 exercise countermeasures, Cardio-Oncol Lond Engl, vol.2, 2016. ,
Congestive heart failure in patients treated with doxorubicin: a 450 retrospective analysis of three trials, Cancer, vol.97, pp.2869-2879, 2003. ,
Cardiotoxicity of 452 anthracycline agents for the treatment of cancer: systematic review and meta-analysis of 453 randomised controlled trials, BMC Cancer, vol.10, p.337, 2010. ,
Risk of severe 455 cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort 456 studies of 29,000 women with breast cancer, Intern Emerg Med, vol.11, pp.123-140, 2016. ,
Risk of cardiac dysfunction with trastuzumab in 458 breast cancer patients: a meta-analysis, Cancer Treat Rev, vol.37, pp.312-320, 2011. ,
2-year follow-up 460 of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised 461 controlled trial, Lancet Lond Engl, vol.369, pp.29-36, 2007. ,
, Asteggiano, vol.463
ESC Position Paper on cancer treatments and 464 cardiovascular toxicity developed under the auspices of the ESC Committee for Practice 465 Guidelines, Eur J Heart Fail, vol.19, pp.9-42, 2016. ,
Longer-term 467 assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) 468 trial, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, pp.3422-3428, 2010. ,
470 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer, N Engl J Med, vol.471, pp.1659-1672, 2005. ,
Cardiotoxicity of trastuzumab in clinical practice, N Engl J Med, vol.473, pp.94-95, 2007. ,
Molecular and cellular mechanisms of 475 anthracycline cardiotoxicity, Cardiovasc Toxicol, vol.7, pp.114-121, 2007. ,
Anthracycline-induced 477 cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron, Pharmacol Rep PR, vol.478, pp.154-171, 2009. ,
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis ,
, Cardiovasc Toxicol, vol.7, pp.101-107, 2007.
Acute doxorubicin 482 cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin 483 pathway, Circulation, vol.119, pp.99-106, 2009. ,
Human breast cancer: 485 correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.486, pp.177-182, 1987. ,
Multinational 488 study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who 489 have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy 490 for metastatic disease, J Clin Oncol Off J Am Soc Clin Oncol, vol.17, pp.2639-2648, 1999. ,
Phase II study 492 of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-493 weekly schedule, J Clin Oncol Off J Am Soc Clin Oncol, vol.23, pp.2162-2171, 2005. ,
Use of 495 chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that 496 overexpresses HER2, N Engl J Med, vol.344, pp.783-792, 2001. ,
Randomized 498 phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with 499 human epidermal growth factor receptor 2-positive metastatic breast cancer administered as 500 first-line treatment: the M77001 study group, J Clin Oncol Off J Am Soc Clin Oncol, vol.501, pp.4265-4274, 2005. ,
Down-regulation of 503 the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related 504 apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that 505 overexpress erbB-2, Cancer Res, vol.61, pp.4892-4900, 2001. ,
Trastuzumab plus 507 adjuvant chemotherapy for operable HER2-positive breast cancer, N Engl J Med, vol.508, pp.1673-1684, 2005. ,
Trastuzumab-induced 510 cardiotoxicity: heart failure at the crossroads, Mayo Clin Proc, vol.83, pp.197-203, 2008. ,
Trastuzumab-induced 512 cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and 513 protective factors, Heart Br Card Soc, vol.99, pp.634-639, 2013. ,
Trastuzumab-related cardiac events in the treatment of early 515 breast cancer, Breast Cancer Res Treat, vol.142, pp.1-7, 2013. ,
Breast 517 Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical 518 Practice: A Population-Based Cohort Study, J Clin Oncol Off J Am Soc Clin Oncol, vol.34, pp.2239-519, 2016. ,
Trastuzumab containing 521 regimens for early breast cancer, Cochrane Database Syst Rev, vol.006243, 2012. ,
Cardio-oncology in 523 targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors, Future Cardiol, vol.7, pp.693-704, 2011. ,
Activation of AMP-activated protein 526 kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells ,
, Proc Natl Acad Sci U S A, vol.104, pp.10607-10612, 2007.
ErbB receptors, their ligands, and the consequences of their 529 activation and inhibition in the myocardium, J Mol Cell Cardiol, vol.44, pp.831-854, 2008. ,
Neuregulins promote 531 survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal 532 and adult ventricular myocytes, J Biol Chem, vol.273, pp.10261-10269, 1998. ,
,
, EGF-like growth factor and ErbB signaling is essential for heart function, Proc Natl Acad Sci, vol.100, pp.3221-3226, 2003.
The vulnerability of the heart as a pluricellular 537 paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer 538 therapy, Circ Res, vol.106, pp.35-46, 2010. ,
ERBB2 inhibition and heart failure, N Engl J Med, vol.540, p.876, 2013. ,
Cardiac dysfunction in the 542 trastuzumab clinical trials experience, J Clin Oncol Off J Am Soc Clin Oncol, vol.20, pp.1215-1221, 2002. ,
Trastuzumab in the adjuvant 544 treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized 545 controlled trials, The Oncologist, vol.13, pp.620-630, 2008. ,
Risk of heart 547 failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective 548 cohort study, J Natl Cancer Inst, vol.104, pp.1293-1305, 2012. ,
Pertuzumab plus trastuzumab 550 in combination with standard neoadjuvant anthracycline-containing and anthracycline-free 551 chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized 552 phase II cardiac safety study (TRYPHAENA), Ann Oncol Off J Eur Soc Med Oncol, vol.24, pp.2278-553, 2013. ,
Cardiotoxicity of novel HER2-targeted therapies, Curr Med 555 Res Opin, vol.29, pp.1015-1024, 2013. ,
Effects of supervised exercise training 557 on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment, Cancer, vol.110, pp.918-925, 2007. ,
Effects of exercise training on 560 fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor 561 binding proteins in postmenopausal breast cancer survivors ,
, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, vol.563, pp.721-727, 2003.
Effects of home-565 based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant 566 chemotherapy (SAPA): a randomized controlled trial, Eur J Phys Rehabil Med, vol.52, pp.223-232, 2016. ,
Effects of concurrent 568 aerobic and strength training on breast cancer survivors: a pilot study, Public Health, vol.569, pp.126-132, 2016. ,
Safety and efficacy 571 of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a 572 phase II randomized trial, Acta Oncol Stockh Swed, vol.53, pp.65-74, 2014. ,
Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in 575 overweight and obese breast cancer survivors: a randomized controlled trial, Breast Cancer Res 576 BCR, vol.20, p.124, 2018. ,
Reduction of health risk factors through an adapted physical activity program in patients 579 with breast cancer, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.580, pp.1097-1104, 2014. ,
Cardiopulmonary responses and adherence to 582 exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy, Cancer, vol.583, pp.156-165, 2006. ,
A pilot study of group 585 exercise training (GET) for women with primary breast cancer: feasibility and health benefits, Psychooncology, vol.11, pp.447-456, 2002. ,
Culos-Reed SN: Benefits of 24 versus 12 weeks of exercise 588 and wellness programming for women undergoing treatment for breast cancer. Support Care 589 Cancer Off, J Multinatl Assoc Support Care Cancer, vol.24, pp.4597-4606, 2016. ,
UW WELL-FIT: the impact of supervised exercise 591 programs on physical capacity and quality of life in individuals receiving treatment for cancer ,
, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.20, pp.865-873, 2012.
The effects of exercise on cardiovascular outcomes 594 before, during, and after treatment for breast cancer, Breast Cancer Res Treat, vol.143, pp.219-595, 2014. ,
Early Breast Cancer Therapy and 597 Cardiovascular Injury, J Am Coll Cardiol, vol.50, pp.1435-1441, 2007. ,
Exercise induces a cardiac mitochondrial 599 phenotype that resists apoptotic stimuli, Am J Physiol Heart Circ Physiol, vol.294, pp.928-935, 2008. ,
Exercise-induced cardioprotection--biochemical, 601 morphological and functional evidence in whole tissue and isolated mitochondria, Int J Cardiol, vol.602, pp.16-30, 2007. ,
, , p.604
, Cardiovascular Events in Women With Nonmetastatic Breast Cancer, J Clin Oncol Off J Am Soc, vol.34, pp.2743-2749, 2016.
Adjuvant Trastuzumab 607 Induces Ventricular Remodeling Despite Aerobic Exercise Training, Clin Cancer Res, vol.608, pp.4963-4967, 2009. ,
Effects of aerobic 610 and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a 611 multicenter randomized controlled trial, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, pp.4396-612, 2007. ,
614 Effects of an 18-week exercise programme started early during breast cancer treatment: a 615 randomised controlled trial, BMC Med, vol.13, p.121, 2015. ,
Subgroup 617 effects in a randomised trial of different types and doses of exercise during breast cancer 618 chemotherapy, Br J Cancer, vol.111, pp.1718-1725, 2014. ,
A phase 2 620 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 621 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment 622 by trastuzumab: design of the CARDAPAC study, BMC Cancer, vol.17, p.425, 2017. ,
Weight evolution 624 during endocrine therapy for breast cancer in postmenopausal patients: impact of initial fat 625 mass percentage and previous adjuvant treatments, Clin Breast Cancer ,
Modification of abdominal 628 fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D 629 computed tomography volumetry, Clin Breast Cancer, vol.14, pp.365-370, 2014. ,
A mobile application of breast cancer e-support program 631 versus routine Care in the treatment of Chinese women with breast cancer undergoing 632 chemotherapy: study protocol for a randomized controlled trial, BMC Cancer, vol.17, p.291, 2017. ,
Development of the Physical activity and Your 634 Nutrition for Cancer (PYNC) smartphone app for preventing breast cancer in women, vol.635, p.5, 2017. ,
Efficacy of Mobile Health Care 637 Application and Wearable Device in Improvement of Physical Performance in Colorectal Cancer 638 Patients Undergoing Chemotherapy, Clin Colorectal Cancer, vol.17, pp.353-362, 2018. ,
Barriers to 640 supervised exercise training in a randomized controlled trial of breast cancer patients receiving 641 chemotherapy, Ann Behav Med Publ Soc Behav Med, vol.35, pp.116-122, 2008. ,
Perceived barriers to and 643 facilitators of being physically active during adjuvant cancer treatment, Patient Educ Couns, vol.644, pp.1220-1226, 2016. ,
Factors perceived to influence exercise 646 adherence in women with breast cancer participating in an exercise programme during 647 adjuvant chemotherapy: a focus group study, J Clin Nurs, vol.24, pp.500-510, 2015. ,
I wouldn't have been 649 interested in just sitting round a table talking about cancer"; exploring the experiences of 650 women with breast cancer in a group exercise trial, Health Educ Res, vol.22, pp.827-838, 2007. ,
Breast cancer survivors' barriers and motives for participating in a 652 group-based physical activity program offered in the community, Support Care Cancer Off J, vol.653 ,
, Multinatl Assoc Support Care Cancer, vol.23, pp.2407-2416, 2015.
Understanding barriers to exercise 655 implementation 5-year post-breast cancer diagnosis: a large-scale qualitative study. Health 656, Educ Res, vol.28, pp.843-856, 2013. ,
Barriers to participation in a randomized controlled trial of 658 Qigong exercises amongst cancer survivors: lessons learnt, Asian Pac J Cancer Prev APJCP, vol.659, pp.6337-6342, 2012. ,
De Bourdeaudhuij I: The contribution 661 of general and cancer-related variables in explaining physical activity in a breast cancer 662 population 3 weeks to 6 months post-treatment, Psychooncology, vol.22, pp.203-211, 2013. ,
Barriers to exercise: perspectives from multiethnic cancer survivors 664 in Malaysia, Asian Pac J Cancer Prev APJCP, vol.12, pp.1483-1488, 2011. ,
Exercise among 666 breast and prostate cancer survivors--what are their barriers?, J Cancer Surviv Res Pract, vol.667, pp.413-419, 2011. ,
Health behavior change among breast cancer patients, Int J 669 Public Health, vol.58, pp.603-613, 2013. ,
Exploring social 671 cognitive theory constructs for promoting exercise among breast cancer patients, Cancer Nurs, vol.672, pp.462-473, 2004. ,
Physical Activity During and After Adjuvant 674 Treatment for Breast Cancer: An Integrative Review of Women's Experiences, Integr Cancer 675 Ther, vol.17, pp.16-30, 2018. ,
Negative affect and barriers to exercise among early 677 stage breast cancer patients, Health Psychol Off J Div Health Psychol Am Psychol Assoc, vol.678, pp.275-279, 2008. ,
Effects of an oncologist's recommendation to 680 exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a 681 single-blind, randomized controlled trial, Ann Behav Med Publ Soc Behav Med, vol.28, pp.105-682, 2004. ,
General Practitioners' 684 Barriers to Prescribe Physical Activity: The Dark Side of the Cluster Effects on the Physical 685 Activity of Their Type 2 Diabetes Patients, PloS One, vol.10, p.140429, 2015. ,
Physical activity in patients 687 with type 2 diabetes and hypertension--insights into motivations and barriers from the MOBILE 688 study, Vasc Health Risk Manag, vol.11, pp.361-371, 2015. ,
Main 690 Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print 691 Intervention Among Breast and Prostate Cancer Survivors, J Clin Oncol, vol.25, pp.2709-2718, 2007. ,
Home-based physical activity 693 intervention for breast cancer patients, J Clin Oncol Off J Am Soc Clin Oncol, vol.23, pp.3577-694, 2005. ,
Leading the 696 Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast 697 and prostate cancer survivors, Control Clin Trials, vol.24, pp.206-223, 2003. ,
Behavioral and psychosocial program needs of young 699 adult cancer survivors, Qual Health Res, vol.21, pp.796-806, 2011. ,
Telephone, print, and Web-based 701 interventions for physical activity, diet, and weight control among cancer survivors: a 702 systematic review, J Cancer Surviv Res Pract, vol.9, pp.660-682, 2015. ,
Evaluation of a social cognitive theory-based email 704 intervention designed to influence the physical activity of survivors of breast cancer, Psychooncology, vol.22, pp.829-836, 2013. ,
, Table 1: Physical activity interventions reporting cardiopulmonary outcomes among breast cancer 710 patients during and after treatment
, Adj: Adjuvant; AET: aerobic exercise training; CT: chemotherapy; Ctrl: Control; HR max : maximum 712 heart rate; HT: Hormone therapy; NA: Not applicable; NACT: Neoadjuvant chemotherapy; ND: Not 713 done; RCT: Radiochemotherapy; RET: Resistance exercise training; RM: repetition maximum; RPE: 714 Rate of perceived exertion